Skip to main content
. 2020 Oct;8(19):1231. doi: 10.21037/atm-20-6001

Table 1. Epidemiological and clinical characteristics of confirmed COVID-19 patients.

Characteristics Total (N=159) Nonsevere (N=101) Severe (N=58) P value
Age, median [IQR], years 53 [37–63] 47 [34–58] 63 [54–66] 0.001
Sex, No. (%)
   Male 82 (51.6) 39 (38.6) 43 (74.1) 0.000
   Female 77 (48.4) 62 (61.4) 15 (25.9)
Exposure History within 2 weeks, No. (%)
   Wuhan travel history 129 (81.1) 87 (86.1) 42 (72.4) 0.033
   Contact with suspected patient 25 (15.7) 12 (11.9) 13 (22.4) 0.079
   Contact with confirmed patient 36 (22.6) 28 (27.7) 9 (15.7) 0.049
Signs and symptoms, No. (%)
   Fever 115 (72.3) 63 (62.4) 52 (89.7) 0.000
   Dry cough 62 (39.0) 33 (32.7) 29 (50.0) 0.031
   Myalgia 12 (7.5) 9 (8.9) 3 (5.2) 0.584
   Pharyngalgia 12 (7.5) 10 (9.9) 2 (3.4) 0.242
   Dyspnea 10 (6.3) 5 (5.0) 5 (8.6) 0.563
   Fatigue 9 (5.7) 5 (5.0) 4 (6.9) 0.877
   Diarrhea 7 (4.4) 3 (3.0) 4 (6.9) 0.259
   Stuffy or runny nose 5 (3.1) 2 (2.0) 3 (5.2) 0.355
   Headache or dizziness 4 (2.5) 1 (1.0) 3 (5.2) 0.138
   Nausea or vomiting 2 (1.3) 2 (2.0) 0 (0.0) 0.534
   Chills 1 (0.6) 0 (0.0) 1 (1.7) 0.365
Comorbidity, No. (%)
   Hypertension 21 (13.2) 10 (9.9) 11 (19.0) 0.104
   Diabetes 7 (4.4) 6 (5.9) 1 (1.7) 0.424
   Cardiovascular disease 6 (3.8) 4 (4.0) 2 (3.4) 0.618
   Cancer 1 (0.6) 0 (0.0) 1 (1.7) 0.365
   Other 15 (9.4) 6 (5.9) 9 (15.5) 0.087

COVID-19, coronavirus disease 2019. IQR, interquartile range.